ID
40843
Descripción
Study ID: 103933 Clinical Study ID: NKV103933 Study Title: A non-randomised, open label, two period cross-over study to determine the excretion balance and metabolic disposition of [14C]-GW679769, administered as single doses of an oral solution and an intravenous infusion to healthy male subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced Protocol ID: NKV103933 The eligibility to participate was determined during a screening visit within 21 days prior to first dosing day. The study consisted of two dosing periods, each consisting of predose visit, monitoring after dose administration and prior to discharge visit. Dosing periods were separated by a wash-out period of 43 days. The Concomitant Medications has to be filled in at the Screening Visit and throughout the study whenever a change in patient's medication is made.
Palabras clave
Versiones (1)
- 24/5/20 24/5/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
24 de mayo de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Study of Casopitant Pharmacokinetics in Healthy Males, NKV103933
Concomitant Medications
- StudyEvent: ODM
Descripción
Concomintant Medications
Alias
- UMLS CUI-1
- C2347852
Descripción
If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C0008976
Descripción
List of Concomintant Medications
Alias
- UMLS CUI-1
- C2347852
Descripción
Concomitant Agent Drug Name
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C2360065
Descripción
Concomitant Agent Unit Dose
Tipo de datos
float
Alias
- UMLS CUI [1]
- C2826646
Descripción
Concomitant Agent Unit
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Descripción
Concomitant Agent Frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826654
Descripción
Concomitant Agent Drug Administration Routes
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0013153
Descripción
Concomitant Agent Indication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C3146298
Descripción
Concomitant Agent Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826734
Descripción
Concomitant Agent Start Time
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Descripción
Concomitant Agent Taken Prior to Study?
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826667
Descripción
Concomitant Agent Stop Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826744
Descripción
Concomitant Agent Stop Time
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1522314
Descripción
Concomitant Agent Ongoing
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medications
- StudyEvent: ODM
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C2360065 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])